Related Experiment Video
Updated: May 16, 2026

09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Postoperative radiotherapy for endometrial cancer
Eun Cheol Choi1, Jin Hee Kim, Ok Bae Kim
1Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
Radiation Oncology Journal
|November 22, 2012
Summary
Postoperative radiotherapy alone is an effective and safe treatment for endometrial carcinoma (EC). Stage, operation type, and histologic type are key prognostic factors, but additional treatments are needed to reduce distant metastasis.
Area of Science:
- Gynecology
- Radiation Oncology
- Oncology
Background:
- Endometrial carcinoma (EC) is a common gynecologic malignancy.
- Understanding prognostic factors is crucial for optimizing treatment strategies.
Purpose of the Study:
- To investigate prognostic factors for endometrial carcinoma (EC).
- To evaluate the effectiveness and safety of postoperative radiotherapy alone for EC.
Main Methods:
- Retrospective study of 64 patients with stage I-III EC treated with postoperative radiotherapy alone.
- Patients underwent hysterectomy, salpingo-oophorectomy, and lymphadenectomy.
- Radiotherapy doses ranged from 50.4 Gy to 63 Gy, with some patients receiving intracavitary brachytherapy.
Main Results:
- Five-year overall survival (OS) and disease-free survival (DFS) rates were 58.7% and 59.2%, respectively.
- Stage, menopausal age, operation type, serosal invasion, and lymph node involvement were significant prognostic factors in univariate analysis.
- Stage, operation type, and histologic type were significant in multivariate analysis; distant metastasis was the primary failure pattern.
Conclusions:
- Stage, operation type, and histologic type are predictive prognostic factors for EC.
- Postoperative radiotherapy alone is an effective and safe treatment for EC.
- Further strategies are needed to mitigate distant metastasis in EC patients.
